At $4.43-share, Arotech (NASDAQ:ARTX) shares are massively overvalued and have tremendous risk - we think the stock is worth no more than $2.00-share (55%+ downside). TSLA's recently announced Gigafactory plans has led to mass buying hysteria for any company with lithium-ion battery related technology, including ARTX. The stock was further propelled by two overly-bullish articles that lacked any data to substantiate their claims, one from Zacks Equity Research and the other on Seeking Alpha. As a result, the shares have enjoyed dramatic gains in 2014, rising from $2 to $6 per share, as investors have rushed to join the supercharged party. Unfortunately, investors have chosen to buy first and ask questions later, failing to understand a...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|